Filing Details
DNA X, Inc. (NASDAQ:SONM) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 19, 2026.
The Technology company reported Q0 revenue of .
10q filedNASDAQ:SONM
DNA X, Inc. (SONM) Files Quarterly Report for Q0
DNA X, Inc. (NASDAQ:SONM) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 19, 2026.
At publication ·
What changed
DNA X, Inc. (NASDAQ:SONM) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- DNA X, Inc. (NASDAQ: SONM) filed its quarterly report (Form 10-Q) with the SEC on August 19, 2026.
- The company's stock trades at $3.38 with a market capitalization of $6.3 million.
- The quarterly report includes unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
DNA X, Inc.'s stock currently trades at $3.38 with a market capitalization of $6.3M.
The 10-Q provides DNA X, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for DNA X, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View SONM Stock Page
Frequently Asked Questions
Where can I read SONM's SEC filings?
Browse all filings on our SONM SEC filings page.
What types of SEC filings does DNA X, Inc. file?
Public companies like DNA X, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
